Cargando…

Mortality and years of life lost due to pancreatic cancer in China, its provinces, urban and rural areas from 2005 to 2020: results from the national mortality surveillance system

BACKGROUND: Pancreatic cancer is a growing public health concern in China, and depicting it from different perspectives would provide a comprehensive understanding of its epidemiological characteristics. METHODS: Data from the National Mortality Surveillance System (NMSS) in China was used to estima...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yangyang, Liu, Wei, Long, Zheng, Wang, Lijun, Zhou, Maigeng, Yin, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512506/
https://www.ncbi.nlm.nih.gov/pubmed/37735368
http://dx.doi.org/10.1186/s12885-023-11258-7
_version_ 1785108374906470400
author Xu, Yangyang
Liu, Wei
Long, Zheng
Wang, Lijun
Zhou, Maigeng
Yin, Peng
author_facet Xu, Yangyang
Liu, Wei
Long, Zheng
Wang, Lijun
Zhou, Maigeng
Yin, Peng
author_sort Xu, Yangyang
collection PubMed
description BACKGROUND: Pancreatic cancer is a growing public health concern in China, and depicting it from different perspectives would provide a comprehensive understanding of its epidemiological characteristics. METHODS: Data from the National Mortality Surveillance System (NMSS) in China was used to estimate the number of deaths, years of life lost (YLL), age-standardized mortality rate (ASMR) and age-standardized YLL rate in China, its provinces and urban-rural areas from 2005 to 2020. Joinpoint regression analysis was employed to explore the temporal trends of ASMR and age-standardized YLL rate. Decomposition analysis was conducted to assess the contribution of population growth, population aging and cause-specific mortality rate to the increment of pancreatic cancer deaths. RESULTS: A total of 100,427 pancreatic cancer deaths and 2,166,355 pancreatic cancer related YLL were estimated in China in 2020. The overall ASMR significantly increased from 6.6/100 000 in 2005 to 7.4/100 000 in 2020, and was higher in men than that in women. Age-standardized YLL rate showed a similar trend. The mortality rates of pancreatic cancer were generally higher in northeast China than in southwest China. The highest ASMRs were found in Jilin, Zhejiang, Inner Mongolia and Anhui, and the lowest ones in Guangxi, Yunnan, Tibet, and Hainan. The disease burden due to pancreatic cancer presented a significant upward trend in rural areas and a downward trend in urban areas. CONCLUSIONS: The burden associated with pancreatic cancer had been increasing in China from 2005 to 2020. The escalating disease burden of pancreatic cancer in rural areas necessitates the implementation of effective control and prevention measures. Relevant provinces should pay greater attention to the prevailing of pancreatic cancer, particularly those exhibiting higher mortality rates. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11258-7.
format Online
Article
Text
id pubmed-10512506
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105125062023-09-22 Mortality and years of life lost due to pancreatic cancer in China, its provinces, urban and rural areas from 2005 to 2020: results from the national mortality surveillance system Xu, Yangyang Liu, Wei Long, Zheng Wang, Lijun Zhou, Maigeng Yin, Peng BMC Cancer Research BACKGROUND: Pancreatic cancer is a growing public health concern in China, and depicting it from different perspectives would provide a comprehensive understanding of its epidemiological characteristics. METHODS: Data from the National Mortality Surveillance System (NMSS) in China was used to estimate the number of deaths, years of life lost (YLL), age-standardized mortality rate (ASMR) and age-standardized YLL rate in China, its provinces and urban-rural areas from 2005 to 2020. Joinpoint regression analysis was employed to explore the temporal trends of ASMR and age-standardized YLL rate. Decomposition analysis was conducted to assess the contribution of population growth, population aging and cause-specific mortality rate to the increment of pancreatic cancer deaths. RESULTS: A total of 100,427 pancreatic cancer deaths and 2,166,355 pancreatic cancer related YLL were estimated in China in 2020. The overall ASMR significantly increased from 6.6/100 000 in 2005 to 7.4/100 000 in 2020, and was higher in men than that in women. Age-standardized YLL rate showed a similar trend. The mortality rates of pancreatic cancer were generally higher in northeast China than in southwest China. The highest ASMRs were found in Jilin, Zhejiang, Inner Mongolia and Anhui, and the lowest ones in Guangxi, Yunnan, Tibet, and Hainan. The disease burden due to pancreatic cancer presented a significant upward trend in rural areas and a downward trend in urban areas. CONCLUSIONS: The burden associated with pancreatic cancer had been increasing in China from 2005 to 2020. The escalating disease burden of pancreatic cancer in rural areas necessitates the implementation of effective control and prevention measures. Relevant provinces should pay greater attention to the prevailing of pancreatic cancer, particularly those exhibiting higher mortality rates. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11258-7. BioMed Central 2023-09-21 /pmc/articles/PMC10512506/ /pubmed/37735368 http://dx.doi.org/10.1186/s12885-023-11258-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xu, Yangyang
Liu, Wei
Long, Zheng
Wang, Lijun
Zhou, Maigeng
Yin, Peng
Mortality and years of life lost due to pancreatic cancer in China, its provinces, urban and rural areas from 2005 to 2020: results from the national mortality surveillance system
title Mortality and years of life lost due to pancreatic cancer in China, its provinces, urban and rural areas from 2005 to 2020: results from the national mortality surveillance system
title_full Mortality and years of life lost due to pancreatic cancer in China, its provinces, urban and rural areas from 2005 to 2020: results from the national mortality surveillance system
title_fullStr Mortality and years of life lost due to pancreatic cancer in China, its provinces, urban and rural areas from 2005 to 2020: results from the national mortality surveillance system
title_full_unstemmed Mortality and years of life lost due to pancreatic cancer in China, its provinces, urban and rural areas from 2005 to 2020: results from the national mortality surveillance system
title_short Mortality and years of life lost due to pancreatic cancer in China, its provinces, urban and rural areas from 2005 to 2020: results from the national mortality surveillance system
title_sort mortality and years of life lost due to pancreatic cancer in china, its provinces, urban and rural areas from 2005 to 2020: results from the national mortality surveillance system
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512506/
https://www.ncbi.nlm.nih.gov/pubmed/37735368
http://dx.doi.org/10.1186/s12885-023-11258-7
work_keys_str_mv AT xuyangyang mortalityandyearsoflifelostduetopancreaticcancerinchinaitsprovincesurbanandruralareasfrom2005to2020resultsfromthenationalmortalitysurveillancesystem
AT liuwei mortalityandyearsoflifelostduetopancreaticcancerinchinaitsprovincesurbanandruralareasfrom2005to2020resultsfromthenationalmortalitysurveillancesystem
AT longzheng mortalityandyearsoflifelostduetopancreaticcancerinchinaitsprovincesurbanandruralareasfrom2005to2020resultsfromthenationalmortalitysurveillancesystem
AT wanglijun mortalityandyearsoflifelostduetopancreaticcancerinchinaitsprovincesurbanandruralareasfrom2005to2020resultsfromthenationalmortalitysurveillancesystem
AT zhoumaigeng mortalityandyearsoflifelostduetopancreaticcancerinchinaitsprovincesurbanandruralareasfrom2005to2020resultsfromthenationalmortalitysurveillancesystem
AT yinpeng mortalityandyearsoflifelostduetopancreaticcancerinchinaitsprovincesurbanandruralareasfrom2005to2020resultsfromthenationalmortalitysurveillancesystem